Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  AngioDynamics, Inc.    ANGO

ANGIODYNAMICS, INC. (ANGO)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

AngioDynamics, Inc. : half-yearly earnings release

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/01/2018 | 03:15pm CEST

The company will report its earnings for S1 2018 on 01/04/2018. Generally, the company reports earnings worse than estimates. In recent months, the 3 analysts from Thomson Reuters consensus have not revised their EPS estimates.


© 4-traders.com 2018
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ANGIODYNAMICS, INC.
07/11ANGIODYNAMICS INC : Regulation FD Disclosure, Financial Statements and Exhibits ..
AQ
07/11ANGIODYNAMICS INC : Results of Operations and Financial Condition, Financial Sta..
AQ
07/11ANGIODYNAMICS : Fiscal 4Q Earnings Snapshot
AQ
07/11ANGIODYNAMICS : Reports Fiscal 2018 Fourth Quarter and Full-Year Financial Resul..
BU
07/11ANGIODYNAMICS, INC. : to Host Earnings Call
AC
07/06ANGIODYNAMICS, INC. : annual earnings release
07/05ANGIODYNAMICS : to Report Fiscal 2018 Fourth Quarter and Full-Year Financial Res..
AQ
06/28ANGIODYNAMICS : to Report Fiscal 2018 Fourth Quarter and Full-Year Financial Res..
AQ
06/21ANGIODYNAMICS : to Report Fiscal 2018 Fourth Quarter and Full-Year Financial Res..
BU
04/10ANGIODYNAMICS : to Present at Two Investor Conferences in May
BU
More news
News from SeekingAlpha
07/12AngioDynamics Slowly Building Confidence In Its Turnaround 
07/11AngioDynamics, Inc (ANGO) CEO Jim Clemmer on Q4 2018 Results - Earnings Call .. 
07/11Midday Gainers / Losers (07/11/2018) 
07/11AngioDynamics, Inc. 2018 Q4 - Results - Earnings Call Slides 
07/11AngioDynamics down 12% post Q4 results 
Financials ($)
Sales 2019 345 M
EBIT 2019 45,9 M
Net income 2019 21,5 M
Debt 2019 -
Yield 2019 -
P/E ratio 2019 40,66
P/E ratio 2020 34,72
Capi. / Sales 2019 2,20x
Capi. / Sales 2020 2,16x
Capitalization 758 M
Chart ANGIODYNAMICS, INC.
Duration : Period :
AngioDynamics, Inc. Technical Analysis Chart | ANGO | US03475V1017 | 4-Traders
Technical analysis trends ANGIODYNAMICS, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 4
Average target price 18,5 $
Spread / Average Target -10%
EPS Revisions
Managers
NameTitle
James C. Clemmer President, Chief Executive Officer & Director
Howard W. Donnelly Chairman
Barbara Kucharczyk Senior Vice President-Global Operations
Michael C. Greiner Chief Financial Officer & Executive Vice President
Jeffrey G. Gold Independent Director
Sector and Competitors